Alkermes, Inc. (ALKS)

[surf1944]

7:16AM On The Wires (WIRES) :Alkermes (ALKS) announced completion of patient enrollment in the pivotal, multinational phase 3 study evaluating aripiprazole lauroxil in patients with schizophrenia. Co continues to expect topline results from the phase 3 study in 1H2014. Interim analysis of sample size indicated that sample size of 540 patients or more would have sufficient statistical power to evaluate the primary endpoint.